ConductScience.org, home

Paper42228092

Intratumoral Regulatory T-cell Ablation Mediates Tumor Control Systemically without Autoimmunity.

Bockman A and 8 others. Cancer Res, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Intratumoral Regulatory T-cell Ablation Mediates Tumor Control Systemically without Autoimmunity. Papers, record 42228092. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42228092

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Intratumoral Regulatory T-cell Ablation Mediates Tumor Control Systemically without Autoimmunity.
PubMed
Journal
Cancer Res
PubMed
Year
2026
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-09-22
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
T-Lymphocytes, RegulatoryMajor topic
AutoimmunityMajor topic
NeoplasmsMajor topic
Animals
Mice
Dendritic Cells
Diphtheria Toxin
Forkhead Transcription Factors
Lymphocyte Depletion
Humans

Source PubMed

Download CSV of topics

Grants7

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
DP2 CA247830NCI NIH HHSUnited StatesDP2CA247830PubMedNIH RePORTER
R01 CA292818NCI NIH HHSUnited StatesR01CA292818PubMedNIH RePORTER
1DP2CA247830-01Foundation for the National Institutes of Health (FNIH)DP2CA247830PubMedNIH RePORTER
Pew Charitable Trusts (Pew)PubMedPubMed
St. Baldrick's Foundation (SBF)PubMedPubMed
Gilead Sciences (Gilead)PubMedPubMed
R01CA292818Foundation for the National Institutes of Health (FNIH)R01CA292818PubMedNIH RePORTER

Download CSV of grants

References78

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135296095Mechanisms of MHC-I Downregulation and Role in Immunotherapy Response.Front Immunol2022https://conductscience.org/library/papers/35296095PubMed
224777248Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity through reduction of intratumoral regulatory T cells.Cancer Immunol Res2013https://conductscience.org/library/papers/24777248PubMed
335354899The impact of CCR8+ regulatory T cells on cytotoxic T cell function in human lung cancer.Sci Rep2022https://conductscience.org/library/papers/35354899PubMed
437224815Tumor biology and immune infiltration define primary liver cancer subsets linked to overall survival after immunotherapy.Cell Rep Med2023https://conductscience.org/library/papers/37224815PubMed
518845758CTLA-4 control over Foxp3+ regulatory T cell function.Science2008https://conductscience.org/library/papers/18845758PubMed
619008445Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity.Science2008https://conductscience.org/library/papers/19008445PubMed
731455681A Phase I Study of the Anti-CC Chemokine Receptor 4 Antibody, Mogamulizumab, in Combination with Nivolumab in Patients with Advanced or Metastatic Solid Tumors.Clin Cancer Res2019https://conductscience.org/library/papers/31455681PubMed
840181089Adoptively transferred tumor-specific IL-9-producing cytotoxic CD8+ T cells activate host CD4+ T cells to control tumors with antigen loss.Nat Cancer2025https://conductscience.org/library/papers/40181089PubMed
936352891Differential expression of CCR8 in tumors versus normal tissue allows specific depletion of tumor-infiltrating T regulatory cells by GS-1811, a novel Fc-optimized anti-CCR8 antibody.Oncoimmunology2022https://conductscience.org/library/papers/36352891PubMed
1028486109Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy.Cancer Cell2017https://conductscience.org/library/papers/28486109PubMed
1120332236Multiple antitumor mechanisms downstream of prophylactic regulatory T-cell depletion.Cancer Res2010https://conductscience.org/library/papers/20332236PubMed
1236736322Tissue-specific abundance of interferon-gamma drives regulatory T cells to restrain DC1-mediated priming of cytotoxic T cells against lung cancer.Immunity2023https://conductscience.org/library/papers/36736322PubMed
1329107330Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution.Cell2017https://conductscience.org/library/papers/29107330PubMed
1437392735CXCR3 expression in regulatory T cells drives interactions with type I dendritic cells in tumors to restrict CD8+ T cell antitumor immunity.Immunity2023https://conductscience.org/library/papers/37392735PubMed
1511137993The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3.Nat Genet2001https://conductscience.org/library/papers/11137993PubMed
1635622903Intratumoral immunotherapy relies on B and T cell collaboration.Sci Immunol2022https://conductscience.org/library/papers/35622903PubMed
1736351377Dendritic cells can prime anti-tumor CD8+ T cell responses through major histocompatibility complex cross-dressing.Immunity2022https://conductscience.org/library/papers/36351377PubMed
1810553041Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity.J Immunol1999https://conductscience.org/library/papers/10553041PubMed
1917676052A spatially and temporally restricted mouse model of soft tissue sarcoma.Nat Med2007https://conductscience.org/library/papers/17676052PubMed
2037256255Targeted TLR9 Agonist Elicits Effective Antitumor Immunity against Spontaneously Arising Breast Tumors.J Immunol2023https://conductscience.org/library/papers/37256255PubMed

See all 78 referencesDownload CSV of references

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CCR81237PubTator's text mininghttps://conductscience.org/library/genes/1237NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42228092

GET https://conductscience.org/api/papers/v1/42228092/references?page=2